Icon reports "solid start" to the year
The clinical trials group had net income of $63 million in the first quarter
Clinical trials group Icon reported first quarter net income of $63 million (€56 million), or $1.12 per share, ahead of market expectations and up from $55.9 million, or $0.90 a share, a year earlier.
The company, which recorded a 3.2 per cent rise in net revenue in the three months to the end of March to $400.5 million, said the first quarter represented a solid start to the year.
"We have grown our...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures